tiprankstipranks
Trending News
More News >
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market

Chimeric Therapeutics Ltd. (CHM) Income Statement

Compare
13 Followers

Chimeric Therapeutics Ltd. Income Statement

Last quarter (Q4 2025), Chimeric Therapeutics Ltd.'s total revenue was AU$3.57M, an increase of 405.12% from the same quarter last year. In Q4, Chimeric Therapeutics Ltd.'s net income was AU$-3.79M. See Chimeric Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 3.97MAU$ 7.46MAU$ 0.00AU$ 2.62MAU$ 2.65K
Gross Profit
AU$ 3.12MAU$ 7.45MAU$ 3.54MAU$ 1.67MAU$ -844.31K
Operating Expenses
AU$ 18.23MAU$ 19.77MAU$ 29.49MAU$ 13.62MAU$ 14.00M
Depreciation and Amortization
AU$ 1.03MAU$ 1.01MAU$ 965.35KAU$ 949.76KAU$ 846.96K
EBITDA
AU$ -9.08MAU$ -11.30MAU$ -28.59MAU$ -13.62MAU$ -14.26M
Operating Income
AU$ -15.11MAU$ -12.31MAU$ -29.49MAU$ -14.57MAU$ -14.85M
Other Income/Expenses
AU$ 4.79MAU$ -3.97MAU$ -842.60KAU$ -1.16MAU$ -267.02K
Pretax Income
AU$ -10.32MAU$ -16.28MAU$ -30.33MAU$ -15.73MAU$ -15.11M
Net Income
AU$ -10.43MAU$ -12.53MAU$ -25.92MAU$ -15.90MAU$ -15.11M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.02AU$ -0.06AU$ -0.04AU$ -0.05
Diluted EPS
AU$ -0.01AU$ -0.02AU$ -0.06AU$ -0.04AU$ -0.05
Weighted Average Shares Outstanding
1.35B 695.68M 433.24M 359.93M 325.51M
Weighted Average Shares Outstanding (Diluted)
1.35B 695.64M 433.24M 359.93M 325.50M
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History